 Mastectomy, Segmental
"Mastectomy, Segmental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.
| Descriptor ID |
D015412
|
| MeSH Number(s) |
E04.466.701
|
| Concept/Terms |
Mastectomy, Segmental- Mastectomy, Segmental
- Mastectomies, Segmental
- Segmental Mastectomies
- Segmental Mastectomy
- Segmentectomy
- Segmentectomies
- Partial Mastectomy
- Mastectomies, Partial
- Mastectomy, Partial
- Partial Mastectomies
Limited Resection Mastectomy- Limited Resection Mastectomy
- Limited Resection Mastectomies
- Mastectomies, Limited Resection
- Mastectomy, Limited Resection
- Resection Mastectomies, Limited
- Resection Mastectomy, Limited
- Lumpectomy
- Local Excision Mastectomy
- Excision Mastectomies, Local
- Excision Mastectomy, Local
- Local Excision Mastectomies
- Mastectomies, Local Excision
- Mastectomy, Local Excision
Breast-Conserving Surgery- Breast-Conserving Surgery
- Breast Conserving Surgery
- Breast-Conserving Surgeries
- Surgeries, Breast-Conserving
- Surgery, Breast-Conserving
- Surgery, Breast Conserving
|
Below are MeSH descriptors whose meaning is more general than "Mastectomy, Segmental".
Below are MeSH descriptors whose meaning is more specific than "Mastectomy, Segmental".
This graph shows the total number of publications written about "Mastectomy, Segmental" by people in UAMS Profiles by year, and whether "Mastectomy, Segmental" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2023 | 0 | 2 | 2 | | 2022 | 0 | 1 | 1 | | 2021 | 2 | 1 | 3 | | 2020 | 0 | 1 | 1 | | 2019 | 0 | 1 | 1 | | 2018 | 3 | 1 | 4 | | 2017 | 1 | 3 | 4 | | 2016 | 2 | 2 | 4 | | 2015 | 4 | 0 | 4 | | 2014 | 1 | 1 | 2 | | 2013 | 0 | 2 | 2 | | 2012 | 2 | 0 | 2 | | 2011 | 2 | 0 | 2 | | 2010 | 3 | 1 | 4 | | 2009 | 1 | 0 | 1 | | 2007 | 1 | 2 | 3 | | 2006 | 1 | 2 | 3 | | 2004 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 1999 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mastectomy, Segmental" by people in Profiles over the past ten years.
-
An SJ, Thai CHNC, Ismail S, Agala CB, Hoang V, Feeney T, Lillie M, Wheless A, Selfridge JM, Ollila DW, Gallagher KK, Carey LA, Spanheimer PM. Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution. Ann Surg Oncol. 2024 Dec; 31(13):8786-8794.
-
Chen KA, Kirchoff KE, Butler LR, Holloway AD, Kapadia MR, Kuzmiak CM, Downs-Canner SM, Spanheimer PM, Gallagher KK, Gomez SM. Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status. Ann Surg Oncol. 2023 Nov; 30(12):7107-7115.
-
Weiser R, Manno GC, Cass SH, Chen L, Kuo YF, He J, Robinson AS, Posleman Monetto F, Silva HC, Klimberg VS. Fluoroscopic Intraoperative Breast Neoplasm and Node Detection. J Am Coll Surg. 2023 04 01; 236(4):575-585.
-
Hong MJ, Lum SS, Dupont E, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, Fenton A, Murray M, Solomon NL, Ollila DW, Lazar M, Namm JP, Walters LL, Chagpar AB. Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care. J Surg Res. 2022 11; 279:393-397.
-
Chagpar AB, Dupont E, Chiba A, Levine EA, Gass JS, Lum S, Brown E, Fenton A, Solomon NL, Ollila DW, Murray M, Gallagher K, Howard-McNatt M, Lazar M, Garcia-Cantu C, Walters L, Pandya S, Mendiola A, Namm JP. Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients. Am J Surg. 2022 07; 224(1 Pt A):8-11.
-
Johnson JE, Strassle PD, de Oliveira GC, Agala CB, Spanheimer P, Gallagher K, Ollila D, Muss H, Downs-Canner S. Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients. Breast Cancer Res Treat. 2021 Sep; 189(2):509-520.
-
Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. Ann Surg. 2021 05 01; 273(5):876-881.
-
Chan RJ, Cooper B, Koczwara B, Chan A, Tan CJ, Paul SM, Dunn LB, Conley YP, Kober KM, Levine JD, Miaskowski C. A longitudinal analysis of phenotypic and symptom characteristics associated with inter-individual variability in employment interference in patients with breast cancer. Support Care Cancer. 2020 Oct; 28(10):4677-4686.
-
Downs-Canner SM, Gaber CE, Louie RJ, Strassle PD, Gallagher KK, Muss HB, Ollila DW. Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer. Cancer. 2020 03 15; 126(6):1193-1201.
-
Merrill AY, Ochoa D, Klimberg VS, Hill EL, Preston M, Neisler K, Henry-Tillman RS. Cutting Healthcare Costs with Hematoma-Directed Ultrasound-Guided Breast Lumpectomy. Ann Surg Oncol. 2018 Oct; 25(10):3076-3081.
-
Nayyar A, Strassle PD, Shen MR, Black JA, Gallagher KK, McGuire KP. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection. Am J Surg. 2018 10; 216(4):706-712.
-
Nayyar A, Gallagher KK, McGuire KP. Definition and Management of Positive Margins for Invasive Breast Cancer. Surg Clin North Am. 2018 Aug; 98(4):761-771.
-
Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskj?ld B, Guti?rez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):316-324.
-
Barnard K, Klimberg VS. An Update on Randomized Clinical Trials in Breast Cancer. Surg Oncol Clin N Am. 2017 10; 26(4):587-620.
-
Merrill AY, Brown DR, Klepin HD, Levine EA, Howard-Mcnatt M. Outcomes after Mastectomy and Lumpectomy in Octogenarians and Nonagenarians with Early-Stage Breast Cancer. Am Surg. 2017 Aug 01; 83(8):887-894.
-
Merrill AY, White A, Howard-McNatt M. Paget's Disease of the Breast: An Institutional Review and Surgical Management. Am Surg. 2017 Mar 01; 83(3):e96-98.
-
Shachar SS, Gallagher K, McGuire K, Zagar TM, Faso A, Muss HB, Sweeting R, Anders CK. Multidisciplinary Management of Breast Cancer During Pregnancy. Oncologist. 2017 03; 22(3):324-334.
-
Altorki NK, Kamel MK, Narula N, Ghaly G, Nasar A, Rahouma M, Lee PC, Port JL, Stiles BM. Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non-Small Cell Lung Cancer. J Thorac Oncol. 2016 11; 11(11):1984-1992.
-
Klimberg VS, Rivere A, Peacock L. Alternatives to whole breast irradiation in early breast cancer. Chin Clin Oncol. 2016 Jun; 5(3):39.
-
Jacob JD, Hodge C, Franko J, Pezzi CM, Goldman CD, Klimberg VS. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol. 2016 Jun; 113(7):721-5.
-
Rivere AE, Chiasson KF, Corsetti RL, Fuhrman GM. An Assessment of Margins after Lumpectomy in Breast Cancer Management. Am Surg. 2016 Feb; 82(2):156-60.
-
Klimberg VS. Intraoperative Image-Guided Breast-Conservation Surgery Should be the Gold Standard. Ann Surg Oncol. 2016 Jan; 23(1):4-5.
-
Jeffe DB, P?rez M, Cole EF, Liu Y, Schootman M. The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up. Ann Surg Oncol. 2016 Mar; 23(3):735-43.
-
Telli ML, Jensen KC, Vinayak S, Kurian AW, Lipson JA, Flaherty PJ, Timms K, Abkevich V, Schackmann EA, Wapnir IL, Carlson RW, Chang PJ, Sparano JA, Head B, Goldstein LJ, Haley B, Dakhil SR, Reid JE, Hartman AR, Manola J, Ford JM. Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105. J Clin Oncol. 2015 Jun 10; 33(17):1895-901.
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|